12 Health Care Stocks Moving In Tuesday's After-Market Session

周二盘后交易时段，12只医疗保健股走势

Benzinga · 2023/10/18 05:31

Biocept (NASDAQ:BIOC) shares moved upwards by 109.4% to $1.07 during Tuesday's after-market session. Trading volume for this security closed at 4.8 million, accounting for 264.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
Intelligent Bio Solutions (NASDAQ:INBS) shares moved upwards by 31.44% to $0.4. At the close, Intelligent Bio Solutions's trading volume reached 2.0 million shares. This is 1402.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.8 million.
RVL Pharmaceuticals (NASDAQ:RVLP) stock rose 17.45% to $0.06. RVL Pharmaceuticals's trading volume hit 18.7 million shares by close, accounting for 104.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.6 million.
Virpax Pharmaceuticals (NASDAQ:VRPX) shares rose 14.94% to $0.89. The market value of their outstanding shares is at $10.4 million.
Exagen (NASDAQ:XGN) shares moved upwards by 8.92% to $1.83. The company's market cap stands at $30.8 million.
PaxMedica (NASDAQ:PXMD) stock rose 7.61% to $0.26. The market value of their outstanding shares is at $4.4 million.

Athersys (NASDAQ:ATHX) shares fell 43.9% to $0.06 during Tuesday's after-market session. Athersys's trading volume hit 45.3 million shares by close, accounting for 2010.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.5 million.
Eiger BioPharmaceuticals (NASDAQ:EIGR) stock fell 9.67% to $0.27. The company's market cap stands at $12.0 million.
China SXT Pharmaceuticals (NASDAQ:SXTC) shares declined by 7.53% to $2.95. The market value of their outstanding shares is at $1.6 million.
Ultragenyx Pharmaceutical (NASDAQ:RARE) shares decreased by 6.6% to $34.4. The market value of their outstanding shares is at $2.4 billion.
Bio-Rad Laboratories (NYSE:BIO) stock fell 5.59% to $322.0. The market value of their outstanding shares is at $9.3 billion.
Inspire Veterinary (NASDAQ:IVP) stock fell 5.49% to $0.86. The company's market cap stands at $10.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Biocept (NASDAQ:BIOC) shares moved upwards by 109.4% to $1.07 during Tuesday's after-market session. Trading volume for this security closed at 4.8 million, accounting for 264.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
Intelligent Bio Solutions (NASDAQ:INBS) shares moved upwards by 31.44% to $0.4. At the close, Intelligent Bio Solutions's trading volume reached 2.0 million shares. This is 1402.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.8 million.
RVL Pharmaceuticals (NASDAQ:RVLP) stock rose 17.45% to $0.06. RVL Pharmaceuticals's trading volume hit 18.7 million shares by close, accounting for 104.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.6 million.
Virpax Pharmaceuticals (NASDAQ:VRPX) shares rose 14.94% to $0.89. The market value of their outstanding shares is at $10.4 million.
Exagen (NASDAQ:XGN) shares moved upwards by 8.92% to $1.83. The company's market cap stands at $30.8 million.
PaxMedica (NASDAQ:PXMD) stock rose 7.61% to $0.26. The market value of their outstanding shares is at $4.4 million.

Biocept 纳斯达克股票代码：BIOC）股价在周二的盘后交易时段上涨109.4％，至1.07美元。该证券的交易量收于480万，占其过去100天平均全天交易量的264.8％。他们流通股的市值为280万美元。
智能生物解决方案 纳斯达克股票代码：INBS）股价上涨31.44％，至0.4美元。收盘时，Intelligent Bio Solutions的交易量达到200万股。这是其过去100天平均交易量的1402.0％。他们流通股的市值为180万美元。
RVL 制药 纳斯达克股票代码：RVLP）股价上涨17.45％，至0.06美元。截至收盘时，RVL Pharmicals的交易量达到1,870万股，占其过去100天平均交易量的104.7％。他们流通股的市值为660万美元。
Virpax 制药 纳斯达克股票代码：VRPX）股价上涨14.94％，至0.89美元。他们流通股的市值为1,040万美元。
Exagen 纳斯达克股票代码：XGN）股价上涨8.92％，至1.83美元。该公司的市值为3,080万美元。
PaxMedica 纳斯达克股票代码：PXMD）股价上涨7.61％，至0.26美元。他们流通股的市值为440万美元。

Athersys (NASDAQ:ATHX) shares fell 43.9% to $0.06 during Tuesday's after-market session. Athersys's trading volume hit 45.3 million shares by close, accounting for 2010.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.5 million.
Eiger BioPharmaceuticals (NASDAQ:EIGR) stock fell 9.67% to $0.27. The company's market cap stands at $12.0 million.
China SXT Pharmaceuticals (NASDAQ:SXTC) shares declined by 7.53% to $2.95. The market value of their outstanding shares is at $1.6 million.
Ultragenyx Pharmaceutical (NASDAQ:RARE) shares decreased by 6.6% to $34.4. The market value of their outstanding shares is at $2.4 billion.
Bio-Rad Laboratories (NYSE:BIO) stock fell 5.59% to $322.0. The market value of their outstanding shares is at $9.3 billion.
Inspire Veterinary (NASDAQ:IVP) stock fell 5.49% to $0.86. The company's market cap stands at $10.2 million. See Also:

阿瑟西斯 纳斯达克股票代码：ATHX）股价在周二的盘后交易时段下跌43.9％，至0.06美元。截至收盘时，Athersys的交易量达到4530万股，占其过去100天平均交易量的2010.9％。他们流通股的市值为150万美元。
艾格生物制药 纳斯达克股票代码：EIGR）股价下跌9.67％，至0.27美元。该公司的市值为1,200万美元。
中国苏轩堂药业 纳斯达克股票代码：SXTC）股价下跌7.53％，至2.95美元。他们流通股的市值为160万美元。
Ultragenyx 制药 纳斯达克股票代码：RARE）股价下跌6.6％，至34.4美元。他们流通股的市值为24亿美元。
生物射线实验室 纽约证券交易所代码：BIO）股价下跌5.59％，至322.0美元。他们流通股的市值为93亿美元。
激励兽医 纳斯达克股票代码：IVP）股价下跌5.49％，至0.86美元。该公司的市值为1,020万美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

译文内容由第三方软件翻译。

以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。

风险及免责提示